|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02162 KEYMED BIO-B
Nominal 
29.800 -1.950 (-6.142%) Non-current Assets
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Investment Properties | 0 | -- | 0 | 0 | 0 | 0 |
| Property, plant, equip. & others | 803,347 | 45.125% | 553,556 | 139,419 | 100,992 | 96,465 |
| Land & other Lease Assets | 90,390 | 192.733% | 30,878 | 38,111 | 23,823 | 28,902 |
| Intangible Assets | 1,110 | -25.802% | 1,496 | 1,104 | 109 | 0 |
| Interests in Asso. & JCEs | 5,822 | -44.920% | 10,570 | 20,281 | 0 | 0 |
| Other Non-current Assets | 42,722 | 65.320% | 25,842 | 153,591 | 24,104 | 14,806 |
| 943,391 | 51.587% | 622,342 | 352,506 | 149,028 | 140,173 | |
Current Assets
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||
| Inventories | 56,354 | 26.652% | 44,495 | 16,393 | 6,846 | 3,306 | |
| Trade Receivables | 16,091 | -- | 0 | 0 | 0 | 0 | |
| Cash & Bank Balances | 851,029 | 40.883% | 604,070 | 1,520,619 | 199,409 | 432,608 | |
| Other Current Assets | 2,016,057 | -24.249% | 2,661,409 | 2,044,937 | 174,662 | 82,491 | |
| Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | |
| 2,939,531 | -11.192% | 3,309,974 | 3,581,949 | 380,917 | 518,405 | ||
Current Liabilities
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |||
| Trade Payables | 29,488 | 97.734% | 14,913 | 2,784 | 3,418 | 3,478 | ||
| S-T Debt & Leases | 65,252 | -9.675% | 72,241 | 11,724 | 4,178 | 4,430 | ||
| Other Current Liabilities | 219,440 | -24.989% | 292,545 | 97,567 | 72,644 | 63,682 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | ||
| 314,180 | -17.256% | 379,699 | 112,075 | 80,240 | 71,590 | |||
| Net Current Assets | 2,625,351 | -10.406% | 2,930,275 | 3,469,874 | 300,677 | 446,815 | ||
| Total Assets Less Current Liabilities | 3,568,742 | 0.454% | 3,552,617 | 3,822,380 | 449,705 | 586,988 | ||
Non-current Liabilities
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||||
| L-T Debt & Leases | 353,457 | 610.781% | 49,728 | 26,985 | 20,314 | 24,271 | |||
| Other Non-current Liabilities | 228,472 | 39.592% | 163,671 | 150,013 | 1,524,194 | 838,672 | |||
| 581,929 | 172.695% | 213,399 | 176,998 | 1,544,508 | 862,943 | ||||
Capital and Reserves
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |||||
| Share Capital | 169 | -0.588% | 170 | 171 | 45 | 45 | ||||
| Reserves | 2,986,142 | -10.598% | 3,340,118 | 3,650,799 | (1,094,583) | (276,000) | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| Shareholders' Funds | 2,986,311 | -10.597% | 3,340,288 | 3,650,970 | (1,094,538) | (275,955) | ||||
| Non-controlling Interests | 502 | -- | (1,070) | (5,588) | (265) | 0 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| 2,986,813 | -10.554% | 3,339,218 | 3,645,382 | (1,094,803) | (275,955) | |||||
Commitments and Contingent Liabilities
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Commitments | 228,008 | 25318.952% | 897 | 254,345 | 1,970 | 10,227 |
| Contingent Liabilities | 0 | -- | 0 | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 27/12/2024 13:31 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -336,745,000 |
| %Change | -- |
| EPS / (LPS) | RMB -1.290 |
| NBV Per Share (¥) | RMB 9.426 |